Bionano Genomics (BNGO) Amortizatization of Intangibles (2021 - 2026)
Bionano Genomics' (BNGO) quarterly Amortizatization of Intangibles came in at $51000.0 in Q1 2026, down 78.93% year-on-year from $242000.0 in Q1 2025, and down 79.52% quarter-over-quarter from $249000.0 in Q4 2025.
Bionano Genomics (BNGO) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Bionano Genomics has disclosed Amortizatization of Intangibles across 6 years of filings, most recently posting $51000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $51000.0, down 78.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $785000.0 (down 9.14% YoY), and the FY2025 annual result was $976000.0, down 25.84% from the prior year.
- Amortizatization of Intangibles came in at $51000.0 for Q1 2026 at Bionano Genomics, down from $249000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $694000.0 in Q1 2024 to a low of -$580000.0 in Q2 2022.
- The 5-year median for Amortizatization of Intangibles is $57000.0 (2022), against an average of $112294.1.
- Across the five-year window, Amortizatization of Intangibles jumped 1260.78% in 2024 and tumbled 78.93% in 2026, its largest moves.
- Bionano Genomics' Amortizatization of Intangibles stood at $57000.0 in 2022, then retreated by 10.53% to $51000.0 in 2023, then jumped by 174.51% to $140000.0 in 2024, then surged by 77.86% to $249000.0 in 2025, then plunged by 79.52% to $51000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $51000.0 (Q1 2026), $249000.0 (Q4 2025), and $236000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 10.20 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 10.05 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 600,000.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 10.06 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Bionano Genomics | 14.01 Mn | -366,620.40 | 3.25 Mn | 51,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,000.00 |
| Mar 31, 2026 | 51,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Sep 30, 2025 | 236,000.00 |
| Sep 30, 2025 | 236,000.00 |
| Jun 30, 2025 | 249,000.00 |
| Jun 30, 2025 | 249,000.00 |
| Mar 31, 2025 | 242,000.00 |
| Mar 31, 2025 | 242,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Mar 31, 2024 | 694,000.00 |
| Mar 31, 2024 | 694,000.00 |
| Dec 31, 2023 | 51,000.00 |
| Dec 31, 2023 | 51,000.00 |